Highlights
KLSE: CARING (5245)       CARING PHARMACY GROUP BHD MAIN : Consumer
Last Price Today's Change   Day's Range   Trading Volume
2.50   0.00 (0.00%)  2.39 - 2.50  30,500
Analyze this stock with MQ Trader system

Financials


Market Cap: 544 Million

Market Cap 544 Million
NOSH 218 Million

Latest Audited Result:  31-May-2017

Latest Audited Result: 31-May-2017
Announcement Date 29-Sep-2017
Next Audited Result: 31-May-2018
Est. Ann. Date: 29-Sep-2018
Est. Ann. Due Date: 27-Nov-2018

Latest Quarter:  31-Aug-2019 [#1]

Latest Quarter: 31-Aug-2019 [#1]
Announcement Date 30-Oct-2019
Next Quarter: 30-Nov-2019
Est. Ann. Date: 24-Jan-2020
Est. Ann. Due Date: 29-Jan-2020
QoQ | YoY   -19.98%  |    2.27%

Annual (Unaudited) ( EPS: 9.52, P/E: 26.26 )

Revenue | NP to SH 599,234  |  20,728
RPS | P/RPS 275.25 Cent  |  0.91
EPS | P/E | EY 9.52 Cent  |  26.26  |  3.81%
DPS | DY | Payout % 5.00 Cent  |  2.00%  |  52.52%
NAPS | P/NAPS 0.70  |  3.57
YoY   11.68%
NP Margin | ROE 4.28%  |  13.60%
F.Y. | Ann. Date 31-May-2019  |  25-Jul-2019

T4Q Result ( EPS: 9.56, P/E: 26.14 )

Revenue | NP to SH 599,049  |  20,819
RPS | P/RPS 275.16 Cent  |  0.91
EPS | P/E | EY 9.56 Cent  |  26.14  |  3.83%
DPS | DY | Payout % 5.00 Cent  |  2.00%  |  52.29%
NAPS | P/NAPS 0.71  |  3.52
QoQ | YoY   0.45%  |    7.35%
NP Margin | ROE 4.33%  |  13.47%
F.Y. | Ann. Date 31-Aug-2019  |  30-Oct-2019

Annualized Result ( EPS: 7.68, P/E: 32.54 )

Revenue | NP to SH 653,024  |  16,724
RPS | P/RPS 299.96 Cent  |  0.83
EPS | P/E | EY 7.68 Cent  |  32.54  |  3.07%
DPS | DY | Payout % -
NAPS | P/NAPS -
QoQ | YoY   -19.32%  |    2.27%
NP Margin | ROE 3.07%  |  10.82%
F.Y. | Ann. Date 31-Aug-2019  |  30-Oct-2019




Show?  YoY % Horiz. %

Last 10 FY Result
AQR T4Q 31/05/19 31/05/18 31/05/17 31/05/16 31/05/15 31/05/14 31/05/13 CAGR
Revenue 653,024 599,049 599,234 508,270 459,957 402,569 366,699 338,337 0 -
  YoY % 9.01% -0.03% 17.90% 10.50% 14.26% 9.78% 8.38% 0.00% -
  Horiz. % 193.01% 177.06% 177.11% 150.23% 135.95% 118.98% 108.38% 100.00% -
PBT 27,112 34,241 33,965 29,566 21,953 12,231 18,499 22,810 0 -
  YoY % -20.82% 0.81% 14.88% 34.68% 79.49% -33.88% -18.90% 0.00% -
  Horiz. % 118.86% 150.11% 148.90% 129.62% 96.24% 53.62% 81.10% 100.00% -
Tax -7,048 -8,323 -8,316 -6,242 -5,164 -3,680 -5,482 -6,534 0 -
  YoY % 15.32% -0.08% -33.23% -20.88% -40.33% 32.87% 16.10% 0.00% -
  Horiz. % 107.87% 127.38% 127.27% 95.53% 79.03% 56.32% 83.90% 100.00% -
NP 20,064 25,918 25,649 23,324 16,789 8,551 13,017 16,276 0 -
  YoY % -22.59% 1.05% 9.97% 38.92% 96.34% -34.31% -20.02% 0.00% -
  Horiz. % 123.27% 159.24% 157.59% 143.30% 103.15% 52.54% 79.98% 100.00% -
NP to SH 16,724 20,819 20,728 18,560 13,130 7,289 12,869 15,078 0 -
  YoY % -19.67% 0.44% 11.68% 41.36% 80.13% -43.36% -14.65% 0.00% -
  Horiz. % 110.92% 138.08% 137.47% 123.09% 87.08% 48.34% 85.35% 100.00% -
Tax Rate 26.00 % 24.31 % 24.48 % 21.11 % 23.52 % 30.09 % 29.63 % 28.65 % - % -
  YoY % 6.95% -0.69% 15.96% -10.25% -21.83% 1.55% 3.42% 0.00% -
  Horiz. % 90.75% 84.85% 85.45% 73.68% 82.09% 105.03% 103.42% 100.00% -
Total Cost 632,960 573,131 573,585 484,946 443,168 394,018 353,682 322,061 0 -
  YoY % 10.44% -0.08% 18.28% 9.43% 12.47% 11.40% 9.82% 0.00% -
  Horiz. % 196.53% 177.96% 178.10% 150.58% 137.60% 122.34% 109.82% 100.00% -
Net Worth 154,571 154,571 152,394 143,686 130,623 121,915 119,738 113,207 - -
  YoY % 0.00% 1.43% 6.06% 10.00% 7.14% 1.82% 5.77% 0.00% -
  Horiz. % 136.54% 136.54% 134.62% 126.92% 115.38% 107.69% 105.77% 100.00% -
Dividend
AQR T4Q 31/05/19 31/05/18 31/05/17 31/05/16 31/05/15 31/05/14 31/05/13 CAGR
Div - 10,885 10,885 10,885 6,531 3,265 4,354 6,531 - -
  YoY % 0.00% 0.00% 0.00% 66.67% 100.00% -25.00% -33.33% 0.00% -
  Horiz. % 0.00% 166.67% 166.67% 166.67% 100.00% 50.00% 66.67% 100.00% -
Div Payout % - % 52.29 % 52.52 % 58.65 % 49.74 % 44.80 % 33.83 % 43.32 % - % -
  YoY % 0.00% -0.44% -10.45% 17.91% 11.03% 32.43% -21.91% 0.00% -
  Horiz. % 0.00% 120.71% 121.24% 135.39% 114.82% 103.42% 78.09% 100.00% -
Equity
AQR T4Q 31/05/19 31/05/18 31/05/17 31/05/16 31/05/15 31/05/14 31/05/13 CAGR
Net Worth 154,571 154,571 152,394 143,686 130,623 121,915 119,738 113,207 - -
  YoY % 0.00% 1.43% 6.06% 10.00% 7.14% 1.82% 5.77% 0.00% -
  Horiz. % 136.54% 136.54% 134.62% 126.92% 115.38% 107.69% 105.77% 100.00% -
NOSH 217,706 217,706 217,706 217,706 217,706 217,706 217,706 217,706 - -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% -
Ratio Analysis
AQR T4Q 31/05/19 31/05/18 31/05/17 31/05/16 31/05/15 31/05/14 31/05/13 CAGR
NP Margin 3.07 % 4.33 % 4.28 % 4.59 % 3.65 % 2.12 % 3.55 % 4.81 % - % -
  YoY % -29.10% 1.17% -6.75% 25.75% 72.17% -40.28% -26.20% 0.00% -
  Horiz. % 63.83% 90.02% 88.98% 95.43% 75.88% 44.07% 73.80% 100.00% -
ROE 10.82 % 13.47 % 13.60 % 12.92 % 10.05 % 5.98 % 10.75 % 13.32 % - % -
  YoY % -19.67% -0.96% 5.26% 28.56% 68.06% -44.37% -19.29% 0.00% -
  Horiz. % 81.23% 101.13% 102.10% 97.00% 75.45% 44.89% 80.71% 100.00% -
Per Share
AQR T4Q 31/05/19 31/05/18 31/05/17 31/05/16 31/05/15 31/05/14 31/05/13 CAGR
RPS 299.96 275.16 275.25 233.47 211.27 184.91 168.44 155.41 - -
  YoY % 9.01% -0.03% 17.90% 10.51% 14.26% 9.78% 8.38% 0.00% -
  Horiz. % 193.01% 177.05% 177.11% 150.23% 135.94% 118.98% 108.38% 100.00% -
EPS 7.68 9.56 9.52 8.53 6.03 3.35 5.91 7.47 0.00 -
  YoY % -19.67% 0.42% 11.61% 41.46% 80.00% -43.32% -20.88% 0.00% -
  Horiz. % 102.81% 127.98% 127.44% 114.19% 80.72% 44.85% 79.12% 100.00% -
DPS 0.00 5.00 5.00 5.00 3.00 1.50 2.00 3.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 66.67% 100.00% -25.00% -33.33% 0.00% -
  Horiz. % 0.00% 166.67% 166.67% 166.67% 100.00% 50.00% 66.67% 100.00% -
NAPS 0.7100 0.7100 0.7000 0.6600 0.6000 0.5600 0.5500 0.5200 0.0000 -
  YoY % 0.00% 1.43% 6.06% 10.00% 7.14% 1.82% 5.77% 0.00% -
  Horiz. % 136.54% 136.54% 134.62% 126.92% 115.38% 107.69% 105.77% 100.00% -
Adjusted Per Share Value based on latest NOSH - 217,706
AQR T4Q 31/05/19 31/05/18 31/05/17 31/05/16 31/05/15 31/05/14 31/05/13 CAGR
RPS 299.96 275.16 275.25 233.47 211.27 184.91 168.44 155.41 - -
  YoY % 9.01% -0.03% 17.90% 10.51% 14.26% 9.78% 8.38% 0.00% -
  Horiz. % 193.01% 177.05% 177.11% 150.23% 135.94% 118.98% 108.38% 100.00% -
EPS 7.68 9.56 9.52 8.53 6.03 3.35 5.91 7.47 0.00 -
  YoY % -19.67% 0.42% 11.61% 41.46% 80.00% -43.32% -20.88% 0.00% -
  Horiz. % 102.81% 127.98% 127.44% 114.19% 80.72% 44.85% 79.12% 100.00% -
DPS 0.00 5.00 5.00 5.00 3.00 1.50 2.00 3.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 66.67% 100.00% -25.00% -33.33% 0.00% -
  Horiz. % 0.00% 166.67% 166.67% 166.67% 100.00% 50.00% 66.67% 100.00% -
NAPS 0.7100 0.7100 0.7000 0.6600 0.6000 0.5600 0.5500 0.5200 0.0000 -
  YoY % 0.00% 1.43% 6.06% 10.00% 7.14% 1.82% 5.77% 0.00% -
  Horiz. % 136.54% 136.54% 134.62% 126.92% 115.38% 107.69% 105.77% 100.00% -
Price Multiplier on Financial Quarter End Date
AQR T4Q 31/05/19 31/05/18 31/05/17 31/05/16 31/05/15 31/05/14 31/05/13 CAGR
Date AQR T4Q 31/05/19 31/05/18 31/05/17 31/05/16 29/05/15 30/05/14 - -
Price 2.2500 2.2500 1.9200 1.5500 1.8100 1.7500 1.0000 2.1100 0.0000 -
P/RPS 0.75 0.82 0.70 0.66 0.86 0.95 0.59 1.36 0.00 -
  YoY % -8.54% 17.14% 6.06% -23.26% -9.47% 61.02% -56.62% 0.00% -
  Horiz. % 55.15% 60.29% 51.47% 48.53% 63.24% 69.85% 43.38% 100.00% -
P/EPS 29.29 23.53 20.17 18.18 30.01 52.27 16.92 30.47 0.00 -
  YoY % 24.48% 16.66% 10.95% -39.42% -42.59% 208.92% -44.47% 0.00% -
  Horiz. % 96.13% 77.22% 66.20% 59.67% 98.49% 171.55% 55.53% 100.00% -
EY 3.41 4.25 4.96 5.50 3.33 1.91 5.91 3.28 0.00 -
  YoY % -19.76% -14.31% -9.82% 65.17% 74.35% -67.68% 80.18% 0.00% -
  Horiz. % 103.96% 129.57% 151.22% 167.68% 101.52% 58.23% 180.18% 100.00% -
DY 0.00 2.22 2.60 3.23 1.66 0.86 2.00 1.42 0.00 -
  YoY % 0.00% -14.62% -19.50% 94.58% 93.02% -57.00% 40.85% 0.00% -
  Horiz. % 0.00% 156.34% 183.10% 227.46% 116.90% 60.56% 140.85% 100.00% -
P/NAPS 3.17 3.17 2.74 2.35 3.02 3.13 1.82 4.06 0.00 -
  YoY % 0.00% 15.69% 16.60% -22.19% -3.51% 71.98% -55.17% 0.00% -
  Horiz. % 78.08% 78.08% 67.49% 57.88% 74.38% 77.09% 44.83% 100.00% -
Price Multiplier on Announcement Date
AQR T4Q 31/05/19 31/05/18 31/05/17 31/05/16 31/05/15 31/05/14 31/05/13 CAGR
Date AQR T4Q 25/07/19 24/07/18 27/07/17 29/07/16 28/07/15 31/07/14 - -
Price 2.4500 2.4500 1.9000 1.6500 1.7000 1.6700 1.1000 2.1400 0.0000 -
P/RPS 0.82 0.89 0.69 0.71 0.80 0.90 0.65 1.38 0.00 -
  YoY % -7.87% 28.99% -2.82% -11.25% -11.11% 38.46% -52.90% 0.00% -
  Horiz. % 59.42% 64.49% 50.00% 51.45% 57.97% 65.22% 47.10% 100.00% -
P/EPS 31.89 25.62 19.96 19.35 28.19 49.88 18.61 30.90 0.00 -
  YoY % 24.47% 28.36% 3.15% -31.36% -43.48% 168.03% -39.77% 0.00% -
  Horiz. % 103.20% 82.91% 64.60% 62.62% 91.23% 161.42% 60.23% 100.00% -
EY 3.14 3.90 5.01 5.17 3.55 2.00 5.37 3.24 0.00 -
  YoY % -19.49% -22.16% -3.09% 45.63% 77.50% -62.76% 65.74% 0.00% -
  Horiz. % 96.91% 120.37% 154.63% 159.57% 109.57% 61.73% 165.74% 100.00% -
DY 0.00 2.04 2.63 3.03 1.76 0.90 1.82 1.40 0.00 -
  YoY % 0.00% -22.43% -13.20% 72.16% 95.56% -50.55% 30.00% 0.00% -
  Horiz. % 0.00% 145.71% 187.86% 216.43% 125.71% 64.29% 130.00% 100.00% -
P/NAPS 3.45 3.45 2.71 2.50 2.83 2.98 2.00 4.12 0.00 -
  YoY % 0.00% 27.31% 8.40% -11.66% -5.03% 49.00% -51.46% 0.00% -
  Horiz. % 83.74% 83.74% 65.78% 60.68% 68.69% 72.33% 48.54% 100.00% -

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.


Trade this stock with T+7 trading account. Find out more.
  2 people like this.
 
Kiat Koh why no volume at all
14/10/2016 1:41 PM
sumtookee wow target pice is 3.50..http://bonescythe.blogspot.my/2015/11/caring-golden-vape.html lol
04/04/2017 10:44 AM
Meowyx weird
15/04/2017 9:53 AM
Diamond7 Wa.....up 15 cents!!!!
02/05/2017 9:44 AM
BRAVOZULU good job
02/05/2017 9:47 AM
mfmqqq recommended trading buy for caring..tp3.11...buy, accumulate and hold till year end...buy..good luck..
03/05/2017 9:53 AM
Diamond7 Wa...up again!
What is the good news?
Bonus, share split, special dividend?
03/05/2017 10:09 AM
meistsk3134 caring better than pharma, look like chinese company are more better than malay
15/06/2017 9:58 PM
Yap WT up up up
28/07/2017 9:57 AM
shpg22 Hefty valuation at this price.
28/07/2017 11:22 AM
Yap WT oh dropped
31/07/2017 9:44 PM
monkeyinvestor buy with 40% profit!
28/11/2017 12:32 PM
Hohup Something will happen today ? ;)
29/11/2017 8:34 AM
monkeyinvestor another good buy stocks SEM is a must buy !
28/12/2017 10:29 AM
meistsk3134 Korean plan jnvest in caring. Thing going big
29/12/2017 11:22 AM
Flintstones Mind to share more? Korean plan?
29/12/2017 2:58 PM
sleang Better QoQ results, but price dropped from 2.x to 1.85? Something wrong?
26/01/2018 10:25 AM
luckypunting is time to monitor the movement ...
06/03/2018 11:16 AM
thek Very quiet here, what happen to the plan?
18/04/2018 2:45 PM
LimKL1 好好
18/04/2018 5:07 PM
Flintstones This stock is terrible. No liquidity at all
26/04/2018 12:27 PM
Hustle Tax too high been rip off since listed
26/04/2018 2:31 PM
veron4best corporate tax lower? or what? why latest Q PBT is lower than NP?
29/07/2018 11:02 AM
UnicornP Prospect is good but very the illiquid.
11/02/2019 5:48 PM
kalteh Something is brewing here... last 3 days uptrends with meaningful volume
12/02/2019 4:31 PM
VinLol123 too many competitors,retail shop selling ubat ubat.But that is good for apex health,yspsah and dpharma(ccmbio).
30/07/2019 1:08 PM
RainT CARING biz is different ya

PHARMA
YSPSAH

and others is different

even they are in mdecine related biz

but the value chain that they involve is very different

you cannot compare these company together
14/08/2019 9:16 AM
ocpd Berjaya Corp rumoured to takeover Caring @ RM3.80 / share!
15/08/2019 4:58 PM
shpg22 Better to pressed down to 1.00 and takeover at 1.20/share la. As VT says, why pay more?
21/08/2019 7:07 PM
kalofarmako yup, caring is different from any pharmacy even deorg pun jual ubat-ubatan.
22/08/2019 3:46 PM
kalofarmako It's going up time to buy ! Come on gaiss.

https://klse.i3investor.com/blogs/MYpharmaceuticalnews/221505.jsp
26/08/2019 10:54 AM
kalofarmako Pharmaniaga’s focus on non-concession ops seen to boost profit

https://www.klsescreener.com/v2/news/view/572140
28/08/2019 10:04 AM
kalofarmako Morning!

Something good to read in the morning.

"High time to decide on concession issue"

Read more: https://klse.i3investor.com/blogs/MYpharmaceuticalnews/222426.jsp
30/08/2019 9:08 AM
kalofarmako WOW!!

The positive long-term outlook for Pharmaniaga

Read more: https://klse.i3investor.com/blogs/MYpharmaceuticalnews/223457.jsp
05/09/2019 1:10 PM
kalofarmako DHM explained that Pharmaniaga is only responsible for the logistics of supplying drugs to government health facilities, rather than the supply itself.

Check out here: https://klse.i3investor.com/blogs/MYpharmaceuticalnews/224313.jsp
11/09/2019 10:56 AM
kalofarmako “The big problem is price control, not Pharmaniaga,” says MyCC

Social activist Lim Mah Hui, one of the conductors of the MyCC study, said Pharmaniaga did not have a monopoly over supply but a virtual monopoly over logistics.

Check out: https://klse.i3investor.com/blogs/MYpharmaceuticalnews/224759.jsp
13/09/2019 9:53 AM
Jeffreyteck Once VT touched, good becomes bad?
24/09/2019 9:38 AM
kalofarmako The public need to understand that Pharmaniaga's role as a concessionaire and not immediately liken it to a monopoly. Shared some thoughts in this article (https://klse.i3investor.com/blogs/MYpharmaceuticalnews/228733.jsp). Though it could use a bit more context but hope this can get the conversation going.

Source: http://read.focusmalaysia.my/ePaper/xml_epaper/Focus/05_10_2019/pla_1_Standard/xml_arts/art_52429.htm
07/10/2019 4:23 PM
William Ng This VT is small shareholder's natural enemy
12/10/2019 6:33 PM
ming Haha.. true.. bigger shark than kyy
12/10/2019 6:36 PM
Hafid Overall, Caring has raised its cash balance from RM 77.9 million in 2013 to RM 131.3 million in 2019. Hence, Caring has built itself a solid record of bringing in positive cash flows from operations and opted to split the proceeds half for CAPEX and dividend payments and the remaining half to be retained within its bank account during the period.
21/10/2019 4:03 PM
Hafid Caring has expanded its store network from 46 in 2010 to having a total of 125 outlets in 2019.
As of 1 October 2019, Caring is worth RM 446.30 million in market capitalisation. On 30 August 2019, Caring’s three largest shareholders are as follows:

a.) Motivasi Optima Sdn Bhd - 50.35% - Chong Yeow Siang, Soo Chan Chiew, Tan Lean Boon and Ang Khoon Lim are substantial shareholders of Caring through their stakes in MOSB. As I write, they are members of the company’s board of directors.

b.) Perbadanan Nasional Bhd - 9.61%

c.) Jitumaju Sdn Bhd - 5.29%
Tan Sri Dato’ Seri Vincent Tan Chee Yioun is a substantial shareholder of Caring with a total of 8.90% indirect shareholdings where his stakes are in Jitumaju, U Telemedia Sdn Bhd & Convenience Shopping (Sabah) Sdn Bhd presently.

Five Years Transformation Plan
Caring is embarking on a five-year transformation plan starting in 2020, where it intends to increase its revenue from around RM 600 million in 2019 to as high as RM 1 billion by 2024.

From 2014 to 2019, Caring has generated RM 125.2 million in positive cash flows from operations, RM 11.6 million;interest income and RM 43.8 million from the IPO listing.

Out of RM125.2 million, the compnay has spent RM 35.4 million in net capital expenditures (CAPEX) and RM 31.6 million in dividends to its existing shareholders.

As of 31 May 2019, Caring has RM 153.47 million in shareholders’ equity and RM 7.77 million in non-current liabilities . Thus, its gearing ratio is 5.06%. At that time, Caring has RM 121.27 million in current liabilities and RM 243.07 million in current assets.
21/10/2019 4:12 PM
moneytr33 still worth to buy now? price quite high
23/10/2019 3:23 PM
Jeffreyteck BJ in, price most probably will move in tandem with BJ cos of which BJL and BJG are now around 20, BJM to be delisted soon, etc. Well done.
28/10/2019 6:26 PM
kalofarmako Pharmaniaga's services would be extended until the Cabinet decides on the mechanism to manage the open tender.

source link: https://klse.i3investor.com/blogs/MYpharmaceuticalnews/234024.jsp
https://klse.i3investor.com/blogs/MYpharmaceuticalnews/234024.jsp
06/11/2019 2:58 PM
kalofarmako Pharmaniaga Bhd witnessed a 300% spike in orders, largely from hospitals and government clinics after the government announced the firm’s drugs and medical supply concession would end on Nov 30.

Check this out!!! https://klse.i3investor.com/blogs/MYpharmaceuticalnews/234455.jsp
08/11/2019 10:53 AM
factslim1 Caring Pharmacy Group Bhd reported a net profit of RM4.18 million for its first quarter ended Aug 31, 2019 a 2.3% increase from RM4.09 million in the same quarter of the previous year, attributed to the sales generated from the establishment of 16 new outlets.

Its revenue rose 8.9% to RM163.26 million from RM149.97 million.
08/11/2019 5:58 PM
kalofarmako POSITIVE REACTION ON PHARMANIAGA EXTENSION

Sources Link:https://klse.i3investor.com/blogs/MYpharmaceuticalnews/234829.jsp
11/11/2019 4:44 PM
kalofarmako Check this out!!!

Sources Link:https://klse.i3investor.com/blogs/MYpharmaceuticalnews/234991.jsp
12/11/2019 11:13 AM
kalofarmako PHARMANIAGA STOCK RECORD YEAR’S STRONGEST JUMP

Check this out!!!

https://klse.i3investor.com/blogs/MYpharmaceuticalnews/235081.jsp
12/11/2019 5:21 PM